Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
Aethlon Medical announced the publication of a peer-reviewed study in the International Journal of Molecular Sciences identifying a novel biomarker in Long COVID patients. The research found that Long COVID patients exhibit approximately two-fold higher levels of mannosylated extracellular vesicles which can be captured by the Hemopurifier's affinity resin.
Key figures
- Fold increase
- 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.